Nitric oxide synthesis inhibition enhances bupivacaine cardiotoxicity

Regional Anesthesia

Volumn 21, Issue 3, 1996, Pages 243-248

  Heavner, James E ^a,d   Shi, Bing ^a,b   Pitkänen, Mikko ^a,c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c Toolo Hospital   (Finland)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

arrhythmia; asystole; bupivacaine; N( ) nitro L arginine methyl ester; nitric oxide; seizure

Indexed keywords

BUPIVACAINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASYSTOLE; CARDIOTOXICITY; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG CROSS REACTIVITY; DRUG INHIBITION; DRUG SYNTHESIS; HEART ARRHYTHMIA; LOCAL ANESTHESIA; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANESTHETICS, LOCAL; ANIMALS; ARGININE; ARRHYTHMIA; BRAIN; BUPIVACAINE; HEART; HEMODYNAMIC PROCESSES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029881861     PISSN: 0146521X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. deJong RH. Local anesthetics. St. Louis, Mosby-Year-Book, 1994.
2. Gaily JA, Montague PR, Reeke GN, Edelman GM. The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci U S A 1991: 87: 3547-3551.
3. Ignarro LG. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989: 65: 1-21.
4. Gartwaite J, Charles ST, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988: 336: 385-388.
5. Furchgott RF, Zawadzki JF. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980: 288: 373-376.
6. McFarlane C, Warner DS, Dexter F, Reveiz A, Todd MM. Glutamatergic antagonism: Effects on lido-caine-induced seizures in the rat. Anesth Analg 1994: 78: S278.
7. Witkin JM, Tortella FA. Modulators of N-methyl-D-aspartate protect against diazepam-or phenobarbital-resistant cocaine convulsions. Life Sci 1991: 48: PL51-56.
8. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991: 43: 109-142.
9. Itzhak Y. Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors. Pharmacol Toxicol 1994: 74: 162-166.
10. Zylber-Katz E, Granit L, Levy M. High-performance liquid Chromatographic determination of bupivacaine in human serum. J Chromatogr 1984: 309: 369-374.
11. Johns RA, Moscicki JC, DiFazio CA. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. Anesthesiology 1992: 77: 779-784.
12. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. BrJ Pharmacol 1990: 101: 625-631.
13. G-monomethyl-L-arginine (L-NMMA) in conscious rats. Br J Pharmacol 1990: 99: 103P.
14. G-monethyl-L-arginine (L-NMMA) in conscious rats. J Physiol 1990: 442: 51P.
15. Huang M, Leblanc ML, Hester RL. Systemic and regional hemodynamics after nitric oxide synthase inhibition: Role of a neurogenic mechanism. Am J Physiol 1994: 267: R84-R88.
16. Wainwright CL, Martorana PA. Pirsidomine, a novel nitric oxide donor, suppresses ischemic arrhythmias in anesthetized pigs. Cardiovasc Pharmacol 1993: 22(suppl. 7): S44-S50.
17. Cano J-P, Guillen J-C, Jouve R, Langlet F, Puddu P-E, Rolland P-H, Serradimigni A. Molsidomine prevents post-ischemic ventricular fibrillation in dogs. Br J Pharmacol 1986: 88: 779-789.
18. Wei HM, Weiss HR, Sinha AK, Chi OZ. Effects of nitric oxide synthase inhibition on regional cerebral blood flow and vascular resistance in conscious and isoflurane-anesthetized rats. Anesth Analg 1993: 77: 880-885.
19. Adachi T, Kurata J, Nakao S, Murakawa M, Shichino T, Shirakami G, Shinomura T, Mori K. Nitric oxide synthase inhibitor does not reduce minimum alveolar anesthetic concentration of halothane in rats. Anesth Analg 1994: 78: 1154-1157.